Ricerca avanzata

Arie Sharon is currently working as the VP-Planning, Engineering & Construction at Azrieli Group Ltd.
Previously, he worked as the VP-Engineering & Business Development at Aura Investments Ltd.
Mr. Sharon completed his undergraduate degree at Technion-Israel Institute of Technology.

Arie E. Kotler è presidente, presidente e amministratore delegato di ARKO Corp., amministratore delegato di GPM Investments LLC, presidente e amministratore delegato di GPM Petroleum (DE) LP, amministratore delegato di Haymaker Acquisition Corp. II, un amministratore delegato di Village Pantry LLC e un amministratore delegato di Worsley Operating Co. LLC. È nel consiglio di amministrazione di Noga Financial Instruments (Dollar) Ltd., Noga Financial Instruments (Dollar) Trading 2004 Ltd. e Yahli Group Ltd. Kotler è stato precedentemente impiegato come presidente di Halman Aldubi Investments House Ltd., presidente di Ligad Investments & Building Ltd., presidente di Malrag 2011 Engineering & Construction e presidente e amministratore delegato di Arko Holdings Ltd.

Arie S. Belldegrun è un imprenditore e uomo d'affari che ha fondato 6 aziende, tra cui: Kite Pharma, Inc., Allogene Therapeutics, Inc. e Agensys, Inc. e che è stato a capo di 16 diverse aziende. Attualmente ricopre la posizione di presidente e partner di Two River Group Holdings LLC, presidente di Two River Group Management LLC, presidente di Bellco Capital LLC (che ha fondato nel 2003), presidente di Two Rivers Consulting Corp., presidente di UroGen Pharma Ltd., presidente e partner di Two River Consulting LLC, presidente esecutivo di Allogene Therapeutics, Inc. (che ha fondato nel 2017), Presidente di Kronos Bio, Inc., Co-Presidente di Breakthrough Properties LLC, Senior Managing Director di VV Manager LLC (che ha fondato nel 2017), Senior Managing Director di Vida Ventures LLC (che ha fondato nel 2017) (una controllata di VV Manager LLC) e Presidente di Technology Assessment Group. Arie S. Belldegrun è anche direttore e professore all'UCLA Institute of Urologic Oncology, capo della divisione di oncologia urologica alla David Geffen School of Medicine e Senior Managing Director alla Vida Ventures LLC (che ha fondato nel 2017) e nel consiglio di amministrazione di altre 5 società. Il dottor Belldegrun è stato in precedenza presidente di Arno Therapeutics, Inc. e presidente non esecutivo di Arno Therapeutics, Inc. (una filiale di Arno Therapeutics, Inc.), presidente, presidente e amministratore delegato di Equinor ASA, direttore di Agensys, Inc. (ha fondato la società nel 1997), Presidente esecutivo, Presidente e CEO di Kite Pharma, Inc. (ha fondato l'azienda nel 2009), presidente del comitato per la tecnologia biologica molecolare presso l'American Urological Association Education & Research, Inc., ricercatore presso il National Cancer Institute e membro del Los Angeles Economy & Jobs Committee. Arie S. Belldegrun ha conseguito un dottorato presso la Hebrew University Hadassah Medical School e una laurea al Weizmann Institute of Science.

Arie Mientkavich is currently the Chairman of several organizations, including RDC - Rafael Development Corp.
Ltd., The Movement For Quality Government In Israel, Yad Sarah, RDSeed Ltd., IDB Tourism (2009) Ltd., A.
Mientkavich Consultation Ltd., Hillel Israel Ltd., Yozma Pension Fund of Self Employed Ltd., Migdal Insurance Co. Ltd., Migdal Makcfet Pension & Provident Funds Ltd., and Bloomfield Science Museum.
He is also a Director at Israel Bar Association since 1972.
In the past, he served as the Chairman of Elron Ventures Ltd.
from 2007 to 2015, Vice Chairman of IDB Holding Corp.
Ltd.
from 2010 to 2014, Chairman of Israel Discount Bank Ltd.
from 1997 to 2006, Chairman-Balance Sheet Committee at Mercantile Discount Bank Ltd., Deputy Chairman of G City Ltd.
from 2011 to 2016, Chairman of Clal Tourism Ltd.
from 2007 to 2011, Chairman of Elron Software, Inc., Chairman of Israel Discount Bank of New York, Chairman of Amos Luzon Development & Energy Group Ltd., Vice Chairman-Supervisory Board of Ronson Development SE from 2012 to 2016, Chairman of Gazit Globe Israel (Development) Ltd., Chairman of U.
Dori Construction Ltd.
in 2016, Chairman of U.
Dori Group Ltd., Director at Given Imaging Ltd.
from 2007 to 2014, Director at Migdal Insurance & Financial Holdings Ltd.
from 2019 to 2021, Director at NuLens Ltd., Director at Medingo Ltd., and Member-License Committee at Bank of Israel.
He holds undergraduate and graduate degrees from The Hebrew University of Jerusalem.

Sharon Lim is the founder and the Chairman of Browzwear Solutions Pte Ltd., which was founded in 1999.
She is currently the Chief Executive Officer & Director of Capitaland Malaysia Mall Reit Management Sdn.
Bhd., the Chief Executive Officer & Executive Director of Mapletree Pan Asia Commercial Trust since 2015, and a Director at MPACT Treasury Co. Pte Ltd.
and 80 Alexandra Pte Ltd.
Ms. Lim previously worked as a Manager at CapitaLand Malaysia Trust.
She holds a graduate degree from Murdoch University and an undergraduate degree from RMIT University.

Sharon Sawchak is currently the President & Chief Executive Officer at Axenic Management LLC since 2015.
Prior to this, she worked at GlaxoSmithKline LLC as Senior Director-Clinical Sciences & Neurosciences from 2002 to 2015.
She also worked as Vice President-Clinical Operations & Compliance at Karuna Therapeutics, Inc.

Sharon Barr has a current job as EVP-BioPharmaceuticals Research & Development at AstraZeneca PLC.

Sharon Ritchey ricopre la posizione di Chief Operating Officer & Senior Executive VP presso AXA Financial, Inc. La signora Ritchey fa anche parte del consiglio di amministrazione di QBE Holdings, Inc. In precedenza ha ricoperto la posizione di Chief Operating Officer & Senior Vice President presso The Hartford Financial Services Group, Inc., Chief Operating Officer & Senior Executive VP presso Equitable Financial Life Insurance Company of America, Managing Director-Auto Financial Services presso General Electric Capital Corp., Senior Executive Director & Chief Customer Officer presso Equitable Life Insurance Co. e VP & Product Director-National Marketing presso Citicorp, Inc. Sharon Ritchey ha ricevuto un MBA dalla Kellogg School of Management e un MBA e una laurea presso la Eastern Kentucky University.

Sharon G. Watts occupa la posizione di Chief Administrative Officer presso Leidos Holdings, Inc. In precedenza ha ricoperto la posizione di Vice Presidente-Engineering & Technology alla Lockheed Martin Information Systems & Global Solutions.

Sharon L.
Mates is the founder and currently holds the position of Chairman, President & Chief Executive Officer at ITI, Inc. (New York) since 2002.
She is also the founder and current Chairman & Chief Executive Officer at Intra-Cellular Therapies, Inc. since 2024.
Additionally, Dr. Mates was the founder and former Chairman & Chief Executive Officer at Functional Genetics, Inc. from 2000 to 2003.
She also founded Intra-Cellular Therapies, Inc. in 2013 and serves as Chairman & Chief Executive Officer.
In her current roles, Dr. Mates is the Director-Emerging Company Section at Biotechnology Innovation Organization and an Advisor at The New York City Investment Fund Manager, Inc. Previously, Dr. Mates held the position of Chairman at New York Biotechnology Association, Inc. She was also the President & Director at North American Vaccine, Inc. from 1989 to 1998.
Additionally, she served as a Director at Gilda's Club New York City, Inc.Dr. Mates obtained a doctorate degree from the University of Washington in 1981 and an undergraduate degree from The Ohio State University.

Attualmente, Sharon Gabriel occupa la posizione di responsabile dell'informazione e vicepresidente esecutivo di Clean Harbors, Inc. La signora Gabriel si è laureata al New England College.

Attualmente, Sharon Yeshaya occupa la posizione di amministratore delegato presso Morgan Stanley & Co. LLC. Si è laureata presso la Wharton School of the University of Pennsylvania.

Sharon Gur è Chief Compliance Officer & Head-Compliance alla Bank Leumi Le-Israel Ltd. Si è laureata alla Bar-Ilan University e ha conseguito un MBA alla Bar-Ilan University.

Attualmente, Sharon L. Rolston occupa la posizione di Head-Investor Relations & Group Controller presso Diageo Plc. In passato la signora Rolston ha ricoperto la posizione di presidente di Netas Telekomunikasyon AS.

Sharon R. Barner è un amministratore indipendente di Howmet Aerospace, Inc., un segretario, Chief Legal & Administrative Officer di Cummins, Inc., un membro dell'American Bar Association, un membro dell'Illinois State Bar Association e un membro della National Bar Association. Fa parte del consiglio di amministrazione di Howmet Aerospace, Inc. La signora Barner è stata precedentemente impiegata come direttore indipendente presso Walker Innovation, Inc., vicedirettore presso l'Ufficio brevetti e marchi degli Stati Uniti, e socio e avvocato presso Foley & Lardner LLP. È stata anche membro del consiglio di amministrazione dell'ospedale per bambini La Rabida. Si è laureata alla Syracuse University e si è laureata alla University of Michigan Law School.

Attualmente, Sharon M. Mandell è Chief Information Officer & Senior Vice President di Juniper Networks, Inc. e Chief Information Officer di TIBCO Software, Inc. Nella sua carriera passata la sig.ra Mandell ha occupato la posizione di Vice Presidente-Tecnologia di Tribune Publishing Co., Chief Technology Officer presso Knight-Ridder, Inc., Chief Technology Officer per Knight Ridder Digital e Chief Technology Officer & Senior Vice President presso Cadent Technology, Inc. Ha conseguito una laurea presso la Temple University (Pennsylvania) e un MBA presso la University of Chicago Booth School of Business.

Sharon Chiarella held several positions in different companies, including Senior Director-Digital Home Services at Yahoo!, Principal at Microsoft Corp., Vice President-Technology at Amazon.com, Inc., and VP-Business Development & Product Management at Presto Services, Inc. She also served as Chief Product Officer at Stitch Fix, Inc. in 2021-2022.
Ms. Chiarella earned an MBA degree from Harvard University and an undergraduate degree from Manhattan College.

Sharon M. Solomon occupa la posizione di Chief Information Officer & Senior Vice President di Emergent BioSolutions, Inc. La signora Solomon ha precedentemente ricoperto la posizione di Chief Information Officer di Jacuzzi Brands Corp., Chief Information Officer di MedImmune LLC, Vicepresidente-Information Technology di Actavis, Inc. e Vicepresidente-Information Technology di AstraZeneca LP. La sig.ra Solomon ha conseguito una laurea e una laurea presso l'Università del Maryland.

Attualmente, Sharon Ruth Driscoll occupa la posizione di direttore finanziario alla Ritchie Bros. Auctioneers, Inc. È anche nel consiglio di amministrazione di Empire Co. Ltd. e Sobeys, Inc. ed è membro dei Chartered Professional Accountants of Ontario e membro dei Chartered Professional Accountants of British Columbia. Nella sua carriera passata ha ricoperto la posizione di Chief Financial Officer & SVP-Store Operations presso Sears Canada, Inc., Chief Financial Officer & Executive Vice President di Katz Group Canada Ltd., Senior Vice President-Corporate Development per Loblaw Cos. Ltd. e Senior Vice President-Finance Retail presso Loblaws Supermarkets Ltd. Sharon Ruth Driscoll si è laureata alla Queen's University.

Gil Sharon's current job is as the Director at Educating For Excellence.
Formerly, Mr. Sharon held positions such as President, Chief Executive Officer & Director at Pelephone Communications Ltd.
from 2005 to 2016.
He also served as Chairman & Chief Executive Officer at Golan Telecom Ltd., Chief Marketing Officer & Deputy CEO at Barak 013, Chairman at Bezeq The Israeli Telecommunication Corp.
Ltd., and Independent Director at SHL Telemedicine Ltd.
In addition, Mr. Sharon has worked as a Senior Independent Non-Executive Director at Telit Communications Ltd.
from 2018 to 2021.
He has also served as a Director at Yes Television Plc and Bezeq International Ltd.
.
Mr. Sharon's education includes an MBA from Tel-Aviv University and an undergraduate degree from The Hebrew University of Jerusalem.

Attualmente, Sharon L. McCollam occupa la posizione di presidente e direttore finanziario di Albertsons Cos. McCollam fa anche parte del consiglio di amministrazione di altre 9 società. In passato la signora McCollam ha ricoperto la posizione di EVP, Chief Operating & Financial Officer presso Williams-Sonoma, Inc., Chief Financial & Administrative Officer, EVP presso Best Buy Co., Inc., Chief Financial Officer & Vice President presso Dole Fresh Vegetables, Inc. e Divisional Chief Financial Officer presso Dole Food Co. La signora McCollam ha conseguito una laurea presso la University of Central Oklahoma.

Sharon Goodall has a current job as the Group Head-Regulatory Sciences at British American Tobacco plc since 2018.

Sharon Collins Presnell is currently the Chairman-College of Life Sciences at North Carolina State University and the Director-Coulter Translational Partnership Fund at the University of Virginia.
She is also an Independent Director at Viveve Medical, Inc. and the Chief Scientific Officer at Organovo, Inc. Additionally, she holds positions as a Member of the American Society for Investigative Pathology and the President of the Amnion Foundation.
In the past, Dr. Presnell worked as the Director-Research & Development at Becton, Dickinson & Co. She was also the Senior VP-Regenerative Medicine Research at Tengion, Inc. from 2007 to 2011.
From 2011 to 2018, she served as the Executive Vice President-Research & Development at Organovo Holdings, Inc. She was previously an Assistant Professor at The University of North Carolina at Asheville from 1998 to 2001 and the President & Chief Scientific Officer at Samsara Sciences, Inc.Dr. Presnell obtained her doctorate degree from the Medical College of Virginia.

Sharon Donnelly worked as the Chief Technology & Payments Officer at Bank of Ireland Group Plc.

Sharon Schusheim is currently working as the Chief Service Officer at Check Point Software Technologies Ltd.
He started this position in 2006 and is still currently employed there.
Mr. Schusheim completed his undergraduate degree at Technion-Israel Institute of Technology.

Attualmente, Arie A. van t Hof occupa la posizione di direttore finanziario di HAL Trust. In precedenza ha occupato la posizione di direttore finanziario di HAL Holding NV.

Sharon Xiao Liu occupa la posizione di direttore finanziario per 21Vianet Group, Inc. In passato la signora Liu è stata manager presso KPMG Beijing. La signora Liu si è laureata all'Università di Pechino.

Sharon Arie Schlesinger is currently the Chief Executive Officer and Director of several companies, including Megar - Information Systems Granot Acs Ltd., Granot Regional Cooperative Organization Central Agricultural, Rimon Consulting & Management Services Ltd., Mey Ram Infrastructures Ltd., Merimon Natural Gas North Ltd., Farmer Insurance - Central Cooperative Society Ltd., Mishkei Renewable Energies Ltd., and Siben Solar Project Management Ltd.
He is also a Director of NDrip Ltd., Agro Studies The International Center For Agricultural Interns, Bar Advanced International Education Ltd., Kfar Silver International Agriculture Training Centre, Granot Dagan Ltd., Granot Haroshet Ltd., Granot Shibolet Ltd., Granot Osem Ltd., Avocado - A Packing Institute For Subtropical Fruits, Aloney Granot Cooperative Regional Organization Corp., and Mishkei Solar Energies LP.
He previously worked as a Director at Meshek Energy - Renewable Energies Ltd.
Mr. Schlesinger received an undergraduate degree from Ruppin Academic Institute.

Arie Wolman worked as a Vice President of Sales at Cybonet Security Technologies Ltd., Director of Sales and Marketing at Arelnet Ltd., Director of Regional Sales and Marketing at WaveAccess Ltd., and Regional Director at Harris Adacom Corp.
He completed his undergraduate degree at Technion-Israel Institute of Technology.

Arié started his career in 1999 as an equity proprietary trader at UBP in Geneva.
From 2006 to 2009, he managed a long/short equity hedge fund.
Since 2010, he has been investing in multiple asset classes.
Arié began investing in the Venture Capital space in 2013, and in 2017 teamed up with Amir to found Champel Capital to invest in promising Israeli technology companies.
Arié holds an MS in Economics with a minor in econometrics from the University of Geneva.

Mr. Arie Dekker is an Analyst at Jarden Securities Ltd.
He is also the Head of Research and leads research division, providing clients with insights into New Zealand listed companies.
His team regularly engages with industry contacts, companies, regulatory bodies and a range of other sources to find interesting angles that will help shape clients’ investment decisions.
His areas of expertise include telecommunications and media, dairy, the retirement village sector, and building products.
Mr. Dekker was employed as a Research Analyst by Craigs Investment Partners Ltd., a Senior Investment Analyst by Todd Capital Ltd., Todd Capital Ltd., a Chief Financial Officer & Director by ARA Wines Ltd., an Analyst by Deutsche Bank AG (Broker), and a Principal by First NZ Capital Ltd.
He received his MBS (First Class Honors) from Massey University.

Arie G.
Rubenstein formerly worked at On Track Innovations Ltd., as Secretary & General Counsel.
Mr. Rubenstein received his graduate degree from The College of Management Academic Studies.

Arie Santinge is currently working as a Financial Controller & Compliance officer at Ausnutria Hyproca BV.
He completed his undergraduate degree from Nyenrode Business Universiteit in 1991.

Arie Weber is currently the Chief Executive Officer at Scorpio Investments (A.W.) Ltd., Top Invest (W.M.) Ltd., and holds director positions at Suny Cellular Communication Ltd., Excellence Nessuah Asset Management Ltd., Lapidoth-Heletz LP, Lapidoth-Heletz 2004 (Management) Ltd., Flora Fotonica Ltd., Excellence Nessuah Brokerage Serives Ltd., and E.S.T.
Ecological Systems Ltd.
In the past, Mr. Weber served as the Chief Executive Officer at Alonei Meitar Ltd.
from 2006 to 2009.
He was also the Chairman of The Tel-Aviv Stock Exchange Clearing House Ltd.
and Inventec Investments Ltd.
from 2004 to 2008.
Additionally, he held director positions at Lapidoth Capital Ltd.
and Phoenix Investments House Ltd.
Furthermore, Mr. Weber served as an Independent Director at Capital Point Ltd.
from 2014 to 2023.
He was also a director at The Tel Aviv Stock Exchange (Investment Management) and Purple Biotech Ltd.
.
Mr. Weber's education includes an undergraduate degree and an MBA from Kharkiv National University.

Arie Marcovich is the founder of EyeYon Medical Ltd., which was founded in 2010.

Arie Weintraub worked as a Director at Maman Cargo Terminals & Handling Ltd.
from 2016 to 2019.
He received his undergraduate and MBA degrees from Bar-Ilan University.

Katsutoshi Arie currently works at Seiko IT Solution Co., Ltd., as President & Representative Director from 2006 and Seiko Electric Co., Ltd., as Managing Executive Officer & Head-Information from 2019.

Arie Zigler is associated with two companies, HIL Applied Medical Ltd.
and Resight Ltd.
He is the founder of both companies.
At HIL Applied Medical Ltd., he holds the title of Chief Scientist starting from 2010.
At Resight Ltd, he holds the title of Head-R&D Load starting from 2019.

Arie Sturm is currently the Managing Director at Roxtec BV.

Arie Aigen is the founder of A&A Coating, Inc. He held the title of Chief Executive Officer at the company, although he is no longer active in that role.

Arie Korotkin was the founder and former Chairman of Inter Industries Plus Ltd., which was founded in 1973.

Michel Arié is currently the Deputy Chairman-Management Board at CNIM Development SA. He also holds non-executive director positions at SPI-bio SA, WWS Holdings Ltd., Babcock Wanson Caldeiras Lda., Babcock Wanson España, CNIM Escalators UK Ltd., CNIM CZ sro, CNIM ECS Ltd., and Mese Ltd.
Additionally, he is the Director at Biotec Centre SA, Ellipse Pharmaceuticals SAS, and LAB GmbH.
Mr. Arié is the President of Atena.
In the past, he served as a non-executive director at Le Lab SA, Bertin Technologies SAS, HWS Holdings Ltd., Energonut SpA, MES SELCHP Ltd., Pantech SA, Babcock Wanson UK Ltd., and CNIM UK Ltd.
He was also an independent director at Valerio Therapeutics SA from 2012 to 2013.
Mr. Arié worked as the Head-Finance & Acquisitions at CNIM Group SA from 2010 to 2011.
He completed his undergraduate degree at Institut d’Administration des Entreprises.

Arie Bar Hen has worked as an Operational Manager at Tambour Ltd.
since 2010.

Prior to joining AM Investments, Mr. Berggrun was with Caxton Associates.

Arie Westerlaken formerly worked at DAF Trucks NV, as Director-Legal Affairs from 1990 to 1994, Koninklijke Philips NV, as Secretary & Chief Legal Officer from 1994 to 2010, and BlackRock (Netherlands) BV, as Chief Legal Officer from 1996 to 2007.
Mr. Westerlaken received his graduate degree from the University of Utrecht.

Arie Hochberg currently works at The Blue Card, Inc., as Treasurer & Director.

Arie Trabelsi is currently the Chief Executive Officer at PureRFid, Inc. and the Chief Financial Officer & Director at SuperCom Ltd.
He previously worked as a Director at Sigma Wave Ltd.
Mr. Trabelsi holds a graduate degree from Drexel University and an undergraduate degree from Ben-Gurion University of the Negev.

Arie Carasso-Lev has founded Globe Energy Resources Y.C.D LP in 2009, where he holds the title of Chairman.
He is currently the Chief Executive Officer at Globe International Holdings SA since 2007, at T.D.E.
Recovery Technologies Ltd.
since 2008, and at Pro Line Engineering Services Ltd.
since 1988.
Mr. Carasso-Lev has an undergraduate degree from The California State University.

Arie Kovant has worked as a Director at Let There Be Hemp, Inc. since 2019 and is currently the President of AKA Advertising LLC.